Trading Window Closure Announced by Tatva Chintan Pharma Chem Ltd for FY 2025-2026
Tatva Chintan Pharma Chem Ltd has announced the closure of the trading window for all designated persons and their immediate relatives, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code on prohibition of insider trading. The closure will be effective from Wednesday, 01 April 2026, until 48 hours after the declaration of the audited financial results for the quarter and financial year ending 31 March 2026. Designated persons and their immediate relatives are advised not to trade in the securities of the company during this period.
Key Highlights
- Trading window closure announced for Tatva Chintan Pharma Chem Ltd
- Closure effective from 01 April 2026 until 48 hours after the declaration of audited financial results
- Applies to all designated persons and their immediate relatives
- In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015
- Designated persons advised not to trade in the company's securities during the closure period
Price Impact
More from TATVA
More in Board Meeting
Sambhv Steel Tubes Board Meeting on July 15, 2026 to Consider Fund Raising
Vineet Laboratories Board Meeting on July 15, 2026 for Audited Results
LTM (ex-LTIMindtree) Q1 strong: consol PAT +17% YoY to ₹1,469 Cr, revenue +18%, margins expand